The findings position Intellia to bring to market the first “in vivo” gene editing medicine, though the therapy’s commercial ...
Florida-based biotech company Soilcea developed CarriCea T1, a Carrizo orange variety that is resistant to HLB, also known as ...
Crispr Therapeutics, in collaboration with Vertex, pioneered the first CRISPR-based gene therapy, Casgevy, with regulatory approval in multiple countries, poised for strong revenue growth from Q4 2024 ...
The Pairwise Fulcrum® platform includes proprietary gene editing tools, enzymes, and trait libraries that enable precise genetic changes, unlocking plants’ inherent potential and significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results